KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Invested Capital (2018 - 2025)

Moderna (MRNA) has disclosed Return on Invested Capital for 8 consecutive years, with 0.35% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 2.0% to 0.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.35% through Dec 2025, down 2.0% year-over-year, with the annual reading at 0.32% for FY2025, 1.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.35% at Moderna, up from 0.36% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.96% in Q4 2021, with the low at 0.68% in Q2 2025.
  • Average Return on Invested Capital over 5 years is 0.07%, with a median of 0.08% recorded in 2023.
  • The sharpest move saw Return on Invested Capital surged 123bps in 2021, then plummeted -86bps in 2023.
  • Over 5 years, Return on Invested Capital stood at 0.96% in 2021, then tumbled by -56bps to 0.42% in 2022, then plummeted by -185bps to 0.35% in 2023, then grew by 7bps to 0.33% in 2024, then decreased by -5bps to 0.35% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.35%, 0.36%, and 0.68% for Q4 2025, Q3 2025, and Q2 2025 respectively.